Top entities: Cosmos Health, Nasdaq-100, Greg Siokas.

What category does this event fall under?

Business — classified as listing compliance extension.

What is the sentiment of coverage?

Aggregate sentiment score: 10 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

What were the key actions taken?

Nasdaq-100 granted extension Cosmos Health · Cosmos Health received notification Nasdaq-100 · Cosmos Health does not intend

Is this event still developing?

This is an active story, last updated Jun 11, 2026. Coverage continues to evolve.

Business listing compliance extension

Cosmos Health gets Nasdaq extension

Q: When did this event occur?

First reported Jun 11, 2026; last updated Jun 11, 2026.

Q: What is the market impact?

Direct. The extension granted by Nasdaq-100 provides Cosmos Health with more time to improve its stock price, potentially preventing delisting and offering some stability to investors.

Analysis based on 6 articles · First reported Jun 11, 2026 · Last updated Jun 11, 2026

Sentiment

Attention

Articles

Market Impact

Direct

Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

Market Impact

The extension granted by Nasdaq-100 provides Cosmos Health with more time to improve its stock price, potentially preventing delisting and offering some stability to investors. However, the underlying issue of low bid price remains, indicating continued pressure on Cosmos Health's stock.

Healthcare Pharmaceuticals

Event Summary

Cosmos Health Inc. has been granted an additional 180-day period by Nasdaq-100, extending until December 7, 2026, to regain compliance with the minimum $1.00 bid price requirement. The company is compliant with all other Nasdaq-100 listing requirements. Greg Siokas, CEO of Cosmos Health, stated that the company's primary focus is to regain compliance through business strategy execution and enhancing shareholder value, viewing a reverse stock split as a last resort. This extension provides Cosmos Health with more time to address its stock price challenges.

Key Actions

100 Nasdaq-100 granted extension Cosmos Health

90 Cosmos Health received notification Nasdaq-100

70 Cosmos Health does not intend

Entities Involved

stock

Cosmos Health

Cosmos Health received an additional 180-day extension from Nasdaq-100 to regain compliance with the minimum bid price requirement, which is positive for its continued listing but highlights ongoing stock price challenges.

Importance 100 Sentiment 20

index

Nasdaq-100

Nasdaq-100 granted Cosmos Health an extension, demonstrating its role in regulating listing requirements for publicly traded companies.

Importance 80 Sentiment 0

per

Greg Siokas

Greg Siokas, CEO of Cosmos Health, expressed the company's preference to regain compliance without a reverse stock split, outlining their strategy to enhance shareholder value.

Importance 60 Sentiment 20

NEWSDESK

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard